Logos Global Management

Latest statistics and disclosures from Logos Global Management's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Logos Global Management

Companies in the Logos Global Management portfolio as of the June 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Alx Oncology Hldgs (ALXO) 14.5 $173M 3.2M 54.68
Olema Pharmaceuticals (OLMA) 8.8 $105M 3.7M 27.98
Design Therapeutics (DSGN) 4.6 $54M 2.7M 19.89
Verve Therapeutics 3.8 $46M NEW 758k 60.25
Dyne Therapeutics (DYN) 3.6 $43M -35% 2.1M 21.04
Deciphera Pharmaceuticals (DCPH) 3.4 $40M +1674% 1.1M 36.61
Karuna Therapeutics Ord (KRTX) 3.1 $37M +62% 325k 113.99
Graphite Bio 2.8 $33M NEW 1.1M 30.73
Instil Bio (TIL) 2.8 $33M -8% 1.7M 19.32
Compass Pathways Sponsored Ads (CMPS) 2.7 $32M +240% 850k 38.15
Rapt Therapeutics (RAPT) 2.7 $32M NEW 1.0M 31.79
Nkarta (NKTX) 2.7 $32M -20% 1.0M 31.69
Turning Point Therapeutics I (TPTX) 2.6 $31M +185% 400k 78.02
Kinnate Biopharma (KNTE) 2.6 $31M +42% 1.3M 23.28

Setup an alert

Logos Global Management will file the next quarterly 13-HR in about 2 months. Would you like to be notified?

Forma Therapeutics Hldgs SHS (FMTX) 2.5 $30M -13% 1.2M 24.89
Iovance Biotherapeutics (IOVA) 2.5 $29M NEW 1.1M 26.02
Century Therapeutics 2.4 $29M NEW 989k 29.34
Cytokinetics Com New (CYTK) 2.3 $28M +100% 1.4M 19.79
Edgewise Therapeutics (EWTX) 2.2 $26M +16% 1.2M 21.33
Apellis Pharmaceuticals (APLS) 1.9 $22M NEW 350k 63.20
Bicycle Therapeutics Sponsored Ads (BCYC) 1.8 $22M -10% 715k 30.36
Centessa Pharmaceuticals Sponsored Ads 1.8 $21M NEW 940k 22.21
Biomea Fusion 1.5 $18M NEW 1.2M 15.61
Iveric Bio (ISEE) 1.3 $16M +108% 2.5M 6.31
Gh Research Ordinary Shares 1.3 $16M NEW 724k 21.73
Athira Pharma (ATHA) 1.2 $14M +39% 1.4M 10.24
Janux Therapeutics 1.1 $14M NEW 547k 24.95
Kezar Life Sciences (KZR) 1.0 $13M +187% 2.3M 5.43
Rain Therapeutics 1.0 $12M NEW 780k 15.54
Aclaris Therapeutics (ACRS) 1.0 $12M NEW 675k 17.56
Cogent Biosciences (COGT) 1.0 $12M 1.4M 8.11
Prelude Therapeutics (PRLD) 1.0 $12M NEW 400k 28.63
Kiniksa Pharmaceuticals Com Cl A (KNSA) 0.9 $11M +100% 800k 13.93
Harpoon Therapeutics (HARP) 0.9 $11M +166% 800k 13.87
Eledon Pharmaceuticals (ELDN) 0.9 $11M +497% 1.3M 7.91
Landos Biopharma (LABP) 0.9 $10M +22% 899k 11.55
Repare Therapeutics Ord (RPTX) 0.9 $10M -63% 330k 31.18
Talaris Therapeutics 0.6 $7.5M NEW 508k 14.69
Cullinan Oncology (CGEM) 0.6 $7.4M -30% 289k 25.75
Pmv Pharmaceuticals (PMVP) 0.6 $7.1M +3% 207k 34.16
Monte Rosa Therapeutics 0.6 $6.8M NEW 300k 22.70
Catabasis Pharmaceuticals In Com New (CATB) 0.6 $6.7M NEW 3.2M 2.11
Aslan Pharmaceuticals Ads (ASLN) 0.6 $6.6M -13% 2.0M 3.30
Aligos Therapeutics (ALGS) 0.4 $4.3M -55% 213k 20.39
C4 Therapeutics Com Stk (CCCC) 0.4 $4.3M 113k 37.84
Ikena Oncology (IKNA) 0.4 $4.2M -28% 300k 14.04
Annexon (ANNX) 0.3 $3.6M 160k 22.51
Bctg Acquisition Corp (BCTG) 0.2 $2.3M 200k 11.38
Arya Sciences Acqu Corp Iv Cl A (ARYD) 0.2 $2.1M 200k 10.72
Passage Bio (PASG) 0.1 $1.7M 125k 13.24
Fs Development Corp Ii Com Cl A (FSII) 0.1 $1.2M -58% 124k 9.98
Health Sciences Acq Corp 2 Ord Shs (HSAQ) 0.1 $1.0M -66% 100k 10.20
Research Alliance Corp Ii Com Cl A (RACB) 0.1 $1.0M -66% 100k 10.14
Day One Biopharmaceuticals I 0.1 $844k NEW 37k 22.77
Helix Acquisition Corp Com Cl A (HLXA) 0.0 $518k -75% 50k 10.36
Nuvation Bio *w Exp 07/07/202 (NUVB.WS) 0.0 $173k 67k 2.60
Mereo Biopharma Group Ads (MREO) 0.0 $149k NEW 47k 3.17

Past Filings by Logos Global Management

SEC 13F filings are viewable for Logos Global Management going back to 2019